PremalDilipLullaMD

PubMed

• 2 citations
  The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature.
  Anna Mathioudaki, Xizhe Wang, Richard Huth, Aryan Kamal, Michael Hundemer, Yi Liu, Spyridoula Vasileiou, Carsten Müller-Tidow, Peter Dreger, Thomas Luft, Tim Sauer, Mi...> ;Blood. 2024 Mar 28
• 1 citations
  Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
  LaQuisa C Hill, Rayne H Rouce, Mengfen J Wu, Tao Wang, Royce Ma, Huimin Zhang, Birju Mehta, Natalia Lapteva, Zhuyong Mei, Tyler S Smith, Lina Yang, Madhuwanti Srinivas...> ;Blood. 2024 Mar 28
• Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.
  Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, Paul Shafer, Maksim Mamonkin, LaQuisa C Hill, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Norihi...> ;Blood. 2024 Jan 19
• Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapy.
  Kapadia, C., Thakkar, S., Wu, M., Torrano, V., Wang, T., Grilley, B., Heslop, H., Ramos, C., Goodell, M., Rosas, G., Lulla, P.> ;Cytotherapy. 2024 Mar 1
• 1 citations
  Bringing CAR T cell therapy trials to underserved populations.
  Hoda Badr, Rayne Rouce, Michael E Scheurer, Premal Lulla, Martha Mims, Pavan Reddy> ;Cancer Cell. 2023 Dec 11
• 4 citations
  Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapies.
  David H Quach, Premal Lulla, Cliona M Rooney> ;Blood. 2023 Feb 23
• 1 citations
  Emerging Challenges to Cellular Therapy of Cancer.
  Premal D Lulla, Malcolm Brenner> ;Cancer Journal. 2023 Jan 24
• 21 citations
  Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.
  Thomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu, Carlos Ramos, Ghadir Sasa, Caridad Martinez, Premal Lulla, Robert A Krance, Lauren Scherer, Daniel Ruderfer, Swati Naik...> ;Clinical Cancer Research. 2023 Jan 17
• 1 citations
  Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation.
  Laure Maneix, Polina Iakova, Shannon E Moree, Joanne I Hsu, Ragini M Mistry, Fabio Stossi, Premal Lulla, Zheng Sun, Ergun Sahin, Sarvari V Yellapragada, André Catic> ;Cancer Research Communications. 2022 Dec 1
• 12 citations
  Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients.
  Spyridoula Vasileiou, LaQuisa Hill, Manik Kuvalekar, Aster G Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, Kimberly Mooney, Natalia Lapteva, Bambi J Gril...> ;Haematologica. 2023 Jul 1
• 3 citations
  Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand-Expressing Solid Tumors.
  Pradip Bajgain, Alejandro G Torres Chavez, Kishore Balasubramanian, Lindsey Fleckenstein, Premal Lulla, Helen E Heslop, Juan Vera, Ann M Leen> ;Cancer Immunology Research. 2022 Nov 2
• 8 citations
  Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
  David H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, Carlos A Ramos, Nabil Ahmed, Meenakshi Hegde, Tao Wang, Mengfen Wu, Stephen Gottschalk, Sarah B Whittle, Premal D ...> ;Blood. 2022 Jul 7
• 14 citations
  Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.
  Swati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, Manik Kuvalekar, Ayumi Watanabe, Catherine Robertson, Natalia Lapteva, Wang Tao, Mengfen Wu, Bambi Grilley, George...> ;Blood. 2022 Apr 28
• 1 citations
  Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma.
  Brian D Friend, Ibrahim N Muhsen, Shreeya Patel, LaQuisa C Hill, Premal Lulla, Carlos A Ramos, S Ravi Pingali, Rammurti T Kamble, Tami D John, Baheyeldin Salem, Saleh ...> ;Bone Marrow Transplantation. 2022 Apr 1
• 2 citations
  CAR T cells and autologous transplantation can coexist for DLBCL.
  Premal D Lulla> ;Blood. 2022 Mar 3
• 1 citations
  COVID-specific T's may offset therapeutically endangered B's.
  LaQuisa C Hill, Premal D Lulla> ;Blood. 2022 Jan 6
• 6 citations
  Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer.
  Valentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, Ayumi Watanabe, Ifigeneia Tzannou, Yovana Velazquez, Matthew French-Kim, Wingchi Leung, Suhasini Lulla, Catheri...> ;Therapeutic Advances in Medical Oncology. 2022 Jan 1
• 21 citations
  Allogeneic Transplant and CAR-T Therapy After Autologous Transplant Failure in DLBCL: A Noncomparative Cohort Analysis.
  Mehdi Hamadani, Ajay K. Gopal, Marcelo C. Pasquini, Soyoung Kim, Xianmiao Qiu, Sairah Ahmed, Aleksandr Lazaryan, Vijaya Raj Bhatt, Andrew Daly, Premal Lulla, Stefan O....> ;Blood Advances. 2021 Oct 21
• 13 citations
  Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study.
  Samer Al Hadidi, Deepa Dongarwar, Hamisu M. Salihu, Rammurti T. Kamble, Premal Lulla, La Quisa C. Hill, George Carrum, Carlos A. Ramos, Helen E. Heslop, Saad Z. Usmani> ;Leukemia & Lymphoma. 2021 Jul 18
• 2 citations
  Demographic and Clinical Donor Characteristics as Predictors of Total Nucleated Cell Concentrations in Harvested Marrow Products.
  Brennan Parmelee Streck, Georges Naufal, George Carrum, LaQuisa Hill, Helen E. Heslop, Carlos A. Ramos, Rammurti T. Kamble, Marsha Cohen, Kimberly East, Maria Sena, Pr...> ;Transplantation and Cellular Therapy. 2021 Sep 1
• 4 citations
  Myelodysplastic syndrome and immunotherapy novel to next in-line treatments.
  Premal Lulla> ;Human Vaccines & Immunotherapeutics. 2021 May 3
• 10 citations
  The Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple Myeloma
  Laure Maneix, Melanie A. Sweeney, Sukyeong Lee, Polina Iakova, Shannon Moree, Ergun Sahin, Premal Lulla, Sarvari Venkata Yellapragada, Francis T.F. Tsai, Andre Catic> ;Cancers. 2021 Feb 17
• 22 citations
  T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects.
  Spyridoula Vasileiou, Premal Lulla, Ifigeneia Tzannou, Ayumi Watanabe, Manik Kuvalekar, Wendy L Callejas, Mrinalini Bilgi, Tao Wang, Mengfen J Wu, Rammurti T. Kamble, ...> ;Journal of Clinical Oncology. 2021 Jan 28
• 32 citations
  Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
  Premal Lulla, Swati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, Ayumi Watanabe, Manik Kuvalekar, Suhasini Lulla, George Carrum, Carlos A. Ramos, Rammurti T. Kamble,...> ;Blood. 2021 May 13
• 21 citations
  The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma.
  Premal Lulla, Ifigeneia Tzannou, Spyridoula Vasileiou, George Carrum, Carlos A. Ramos, Rammurti T. Kamble, Tao Wang, Meng-Fen Wu, Mrinalini Bilgi, Adrian P. Gee, Shiva...> ;Science Translational Medicine. 2020 Jul 29
• Join now to see all